IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: PBF Energy
Symbol: PBF
Price: Last trade $31.33
Trade Date: 10/7
Shares: 10 million
Underwriter(s) Morgan Stanley, Credit Suisse
Rating=Subscription Needed
Company: Sarepta Therapeutics, Inc.
Symbol: SRPT
Price: Last trade $41.79
Trade Date: 10/6
Shares: 3 million
Underwriter(s) Credit Suisse, Morgan Stanley
Rating=Subscription Needed
Secondaries announced 10.05.2015